University of British Columbia: Lung Diseases trials

The registry lists 17 Lung Diseases studies with University of British Columbia as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 3 1Phase 4 2No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Using Clinical Prediction Models to Improve Treatment for Patients With Chronic Obstructive Pulmonary Disease (COPD)RecruitingNCT05309356Not applicable
• Trikafta Exercise Study in Cystic FibrosisRecruitingNCT05279040
• Bayis Ilh Tus - A Strong Breath: Prevalence and Contributors to COPD in First Nations Communities in British ColumbiaRecruitingNCT04105088
• CF BronchodilationActive, not recruitingNCT03522831Not applicable
• Diaphragmatic Electrical Activity in Preterm Infants on Non-Invasive VentilationStatus unknownNCT03422549Not applicable
• The Effects of Aerobic Exercise Training on Vascular, Cardiac and Cerebral Vascular Function in COPDCompletedNCT02875522Not applicable
• Resistance Training to Prehabilitate Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02860728Not applicable
• Orkambi Exercise StudyCompletedNCT02821130
• Chronic Obstructive Pulmonary Disease Biomarker StudyStatus unknownNCT02050022
• Evaluating Sensations of Breathlessness in Patients With Cystic FibrosisCompletedNCT01799642
• Mechanisms of Exertional Dyspnea in Fibrotic Interstitial Lung DiseaseCompletedNCT01781793Not applicable
• Educational Interventions for Chronic Obstructive Pulmonary Disease (COPD) Self-management in Ethno-cultural CommunitiesCompletedNCT01474707Not applicable
• Breathing and Bones InitiativeCompletedNCT01161680
• Inhaled Steroid Reduces Systemic Inflammation in COPDCompletedNCT00175565Phase 4
• The Vancouver-BOLD Study: The Burden of Chronic Obstructive Lung DiseaseCompletedNCT00136006
• Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled TrialStatus unknownNCT00120978Phase 4
• Effects of NIMV on the Health Status of Chronic Obstructive Pulmonary Disease (COPD )PatientsTerminatedNCT00114426Phase 3